Doctor taking notes

Resources

Publications

Dec 2022
A Phase 2b Trial in Alcohol-associated Hepatitis to Evaluate the Safety and Efficacy of Larsucosterol Treatment (AHFIRM)
Christina Blevins, Deborah Scott, Gwenaelle Mille, Jina Lee, Gail Friedt, Norman Sussman | SCSG GI Symposium
Nov 2022
The Inpatient Cost and Utilization Impact of Alcohol-associated Hepatitis (AH) Among Traditional Medicare Beneficiaries, 2017-2019
Natalie Marlowe, Robert C. Saunders , Clarisa Peer, Keith Lui, Brendan Gage, Lane Koenig , Norman Sussman | AASLD The Liver Meeting
Jul 2022
Prevalence, Co-Morbidities, And In-Hospital Mortality of Patients Hospitalized with Alcohol-Associated Hepatitis in the United States from 2015 to 2019
Natalie Marlowe, David Lam, William Krebs, WeiQi Lin, Suthat Liangpunsakul | Alcoholism: Clinical and Experimental Research
Nov 2021
Prevalence, Co-Morbidities And In-Hospital Mortality of Hospitalized Alcohol-Associated Hepatitis In US In 2015-2018
Natalie Marlowe, WeiQi Lin, and Suthat Liangpunsakul | AASLD The Liver Meeting
Nov 2021
25-Hydroxycholesterol 3-Sulfate Recovers Acetaminophen Induced Acute Liver Injury via Stabilizing Mitochondria in Mouse Models
Yaping Wang, William M. Pandak, Edward J. Lesnefsky, Phillip B. Hylemon, and Shunlin Ren | Cells

Factsheets

See the resources included here for more information and resources from DURECT.

Corporate Factsheet

Alcohol-Associated Hepatitis Factsheet

AH Phase 2a
Data Factsheet

In the News

Scroll to Top